Taiwan FDA registration c43d8b161c21db0e316d7c86f53c2df9

Abbott clinical biochemical total bilirubin test group

TW: 亞培臨床生化總膽紅素檢驗試劑組
Taiwan flagTaiwan·Risk Class 2·ABBOTT LABORATORIES·Registered Jan 29, 2007 – Jan 29, 2017Cancelled
Registration details
Analysis ID
c43d8b161c21db0e316d7c86f53c2df9
Customs Code
DHA00601789301
Company information
Manufacturer Country
United States
Product details
Intended Use
Quantitative analysis of total red pigment in serum or blood of adult and neonatal children.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1110 Bilirubin (total or direct) test system
Import Information
import
Dates and status
Registration Date
Jan 29, 2007
Expiry Date
Jan 29, 2017
Cancellation Date
Nov 18, 2019
Cancellation information
Status
Logged out
Reason
未展延而逾期者
Companies making similar products

Top companies providing products similar to "Abbott clinical biochemical total bilirubin test group"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Abbott clinical biochemical total bilirubin test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c43d8b161c21db0e316d7c86f53c2df9 and manufactured by ABBOTT LABORATORIES. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations